← All diseases Metabolism and endocrine system

Systemic amyloidosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchStrongest evidence only (28)Meta-analysis (4)Treatment guideline (4)Systematic review (11)Phase 3 study (8)Randomized trial (1)Clinical trial (192)Review article (235)Early study (phase 1 or 2) (17)Case report (283)Laboratory or animal study (21)Commentary or editorial (21) Studies currently recruiting participants only (30)

Filter

Publications and studies (1226)

• Kinetic Transition in Amyloid Assembly as a Screening Assay for Oligomer-Selective Dyes. (2019/09/27) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics. (2019/09/17) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Acquired factor X deficiency in a patient with multiple myeloma: a rare case highlighting the significance of comprehensive evaluation and the need for antimyeloma therapy for bleeding diathesis. (2019/09/16) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Classic features of primary systemic amyloidosis (AL amyloidosis) leading to diagnosis of plasma cell myeloma. (2019/09/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Fibrinogen alpha amyloidosis: insights from proteomics. (2019/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis. (2019/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis. (2019/09/01) ♡
• Crystal structure of 6aJL2-R24G light chain variable domain: Does crystal packing explain amyloid fibril formation? (2019/08/29) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Facial Paralysis as Initial Manifestation of Light-chain Amyloidosis. (2019/08/29) ♡
• Prognostic value of novel imaging parameters derived from standard cardiovascular magnetic resonance in high risk patients with systemic light chain amyloidosis. (2019/08/22) ♡
• Different Dynamics in 6aJL2 Proteins Associated with AL Amyloidosis, a Conformational Disease. (2019/08/21) ♡
• The Early Phase of β2m Aggregation: An Integrative Computational Study Framed on the D76N Mutant and the ΔN6 Variant. (2019/08/14) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hereditary renal amyloidosis with a variant lysozyme p.Trp82Arg in a Chinese family: case report and literature review. (2019/08/08) ♡
• A case of protein-losing gastroenteropathy caused by systemic AA amyloidosis secondary to undifferentiated carcinoma of unknown primary origin. (2019/08/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Usefulness of free light chain measurement in monoclonal gammopathy, other haematological malignancies and autoimmune diseases]. (2019/08/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Multifocal head and neck amyloidosis as a diagnostic clue of systemic lupus erythematosus (SLE): A case report. (2019/08/01) ♡
• Carpal tunnel syndrome and associated symptoms as first manifestation of hATTR amyloidosis. (2019/08/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Intravenous Dose of Miridesap in Healthy Japanese Subjects. (2019/07/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. AMYLOID GOITER AS THE FIRST RECOGNIZABLE MANIFESTATION OF IMMUNOGLOBULIN LIGHT CHAIN AMYLOIDOSIS. (2019/06/26) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Cutaneous light chain amyloidosis with multiple myeloma: A concise review. (2019/06/01) ♡
• Bioimpedance vector analysis for the detection of extracellular volume overload and sarcopenia in systemic AL amyloidosis. (2019/06/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Daratumumab, pomalidomide, and dexamethasone as a bridging therapy to autologous stem cell transplantation in a case of systemic light-chain amyloidosis with advanced cardiac involvement. (2019/06/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diagnosis of amyloid neuropathy. (2019/06/01) ♡
• Rapid progression of aortic and mitral stenosis in a patient with AA amyloidosis: a case report. (2019/06/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Renal amyloidosis complicated by light chain deposition nephropathy: a case report. (2019/06/01) ♡
• Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis. (2019/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review. (2019/04/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Amyloidosis of the Upper Aerodigestive Tract: Management of a Rare Disease and Review of the Literature. (2019/04/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Kidney embolization induces prompt organ response in a 86-year-old patient with MGRS-related AL-amyloidosis. (2019/04/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A novel age-related venous amyloidosis derived from EGF-containing fibulin-like extracellular matrix protein 1. (2019/04/01) ♡
• Primary systemic amyloidosis in patients with Waldenström macroglobulinemia. (2019/03/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Acquired factor X deficiency in light-chain (AL) amyloidosis is rare and associated with advanced disease. (2019/03/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Staging systems use for risk stratification of systemic amyloidosis in the era of high-sensitivity troponin T assay. (2019/02/14) ♡
• Non-Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis. (2019/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Inotersen (transthyretin-specific antisense oligonucleotide) for treatment of transthyretin amyloidosis. (2019/02/01) ♡
• Plasma and Brain Concentrations of Doxycycline after Single and Repeated Doses in Wild-Type and APP23 Mice. (2019/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary idiopathic CNS non-amyloidogenic light chain deposition disease complicated by treatment-resistant focal seizure disorder. (2019/01/01) ♡
• On-Line Immunoaffinity Solid-Phase Extraction Capillary Electrophoresis-Mass Spectrometry for the Analysis of Serum Transthyretin. (2019/01/01) ♡
• [Current diagnosis and treatment of AL amyloidosis in Japan: a nationwide epidemiological survey]. (2019/01/01) ♡
• [A case report of amyloidosis of the larynx in a 13-year-old girl]. (2019/01/01) ♡
• Hepatocyte-Targeted Delivery of siRNA Polyplex with PEG-Modified Lactosylated Dendrimer/Cyclodextrin Conjugates for Transthyretin-Related Amyloidosis Therapy. (2019/01/01) ♡
• [Tumor-like amyloidosis of the upper respiratory tract]. (2019/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Transthyretin Amyloid Neuropathy: The Schwann Cell Hypothesis. (2019/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study to Evaluate Clear Skin Effect on Quality of Life in Patients With Plaque Psoriasis. (2019-09-25) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Safety Study of GSK3039294 in Healthy Volunteers and Patients With Systemic Amyloidosis. (2019-09-23) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type Psoriasis. (2019-07-05) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis. (2019-04-17) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients. (2019-01-23) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Clinical observation of a combination of diffuse alveolar-septal pulmonary lesion and amyloid cardiomyopathy in systemic AL-amyloidosis in the elderly. (2018/12/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Trigeminal Amyloidoma: Case Report and Review of Literature. (2018/12/28) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.